BGIM
BMY icon

Boussard & Gavaudan Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-18,908
Closed -$341K – 28
2019
Q1 		$341K Buy
+18,908
New +$942K 0.01% 20

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boussard & Gavaudan Investment Management's BMY Position: Q2 2019 in Review

Boussard & Gavaudan Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 18,908 shares — an estimated $341K sold.

Boussard & Gavaudan Investment Management first reported a position in BMY in Q1 2019 and held it in 1 quarter. The position peaked at $341K in Q1 2019. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Boussard & Gavaudan Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 18,908 Bristol-Myers Squibb shares in Q2 2019, an estimated $341K.
  • Boussard & Gavaudan Investment Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Bristol-Myers Squibb position peaked at $341K in Q1 2019.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2019, filed 24 Jul 2019.